Oxytocin treatment reduces cancer cachexia in a pre-clinical model (2025)
- Authors:
- Sviercovich, Alexandra
- Watanabe, Etsuko
- Fernandez, Estefania S
- Renzini, Alessandra
- Liu, Chao
- Xie, Grace
- Cao, Jasmine
- Li, Zhenlin
- Agbulut, Onnik
- Seelaender, Marilia Cerqueira Leite
- Otoch, Jose Pinhata
- De Meo, Daniele
- Cera, Gianluca
- Moresi, Viviana
- Palermo, Francesca
- Adamo, Sergio
- Conboy, Michael J
- Conboy, Irina M
- Coletti, Dario
- USP affiliated authors: SEELAENDER, MARILIA CERQUEIRA LEITE - FM ; OTOCH, JOSE PINHATA - HU
- Unidades: FM; HU
- DOI: 10.1016/j.biopha.2025.118825
- Subjects: CAQUEXIA; NEOPLASIAS; OCITOCINA
- Language: Inglês
- Imprenta:
- Source:
- Título: Biomedicine and Pharmacotherapy
- ISSN: 0753-3322
- Volume/Número/Paginação/Ano: v. 193, p. 118825, dec. 2025
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo publicado em periódico de acesso aberto (Gold Open Access) -
ABNT
SVIERCOVICH, Alexandra et al. Oxytocin treatment reduces cancer cachexia in a pre-clinical model. Biomedicine and Pharmacotherapy, v. 193, p. 118825, 2025Tradução . . Disponível em: https://www.sciencedirect.com/science/article/pii/S0753332225010194?via%3Dihub. Acesso em: 15 mar. 2026. -
APA
Sviercovich, A., Watanabe, E., Fernandez, E. S., Renzini, A., Liu, C., Xie, G., et al. (2025). Oxytocin treatment reduces cancer cachexia in a pre-clinical model. Biomedicine and Pharmacotherapy, 193, 118825. doi:10.1016/j.biopha.2025.118825 -
NLM
Sviercovich A, Watanabe E, Fernandez ES, Renzini A, Liu C, Xie G, Cao J, Li Z, Agbulut O, Seelaender MCL, Otoch JP, De Meo D, Cera G, Moresi V, Palermo F, Adamo S, Conboy MJ, Conboy IM, Coletti D. Oxytocin treatment reduces cancer cachexia in a pre-clinical model [Internet]. Biomedicine and Pharmacotherapy. 2025 ; 193 118825.[citado 2026 mar. 15 ] Available from: https://www.sciencedirect.com/science/article/pii/S0753332225010194?via%3Dihub -
Vancouver
Sviercovich A, Watanabe E, Fernandez ES, Renzini A, Liu C, Xie G, Cao J, Li Z, Agbulut O, Seelaender MCL, Otoch JP, De Meo D, Cera G, Moresi V, Palermo F, Adamo S, Conboy MJ, Conboy IM, Coletti D. Oxytocin treatment reduces cancer cachexia in a pre-clinical model [Internet]. Biomedicine and Pharmacotherapy. 2025 ; 193 118825.[citado 2026 mar. 15 ] Available from: https://www.sciencedirect.com/science/article/pii/S0753332225010194?via%3Dihub - High levels of modified ceramides are a defining feature of murine and human cancer cachexia
- Mood, anxiety, and cognitive alterations in cancer patients
- Role of exosomal microRNAs and myomiRs in the development of cancer cachexia-associated muscle wasting
- Proteomic profiling of the tumour microenvironment of cachectic patients: the search for biomarkers
- Circulating hormones and neuropeptides profile in cachectic colorectal cancer patients
- Contribution of the adipose tissue to cachexia-related systemic inflammation in gastrointestinal cancer patients
- Counteracting cancer cachexia-related inflammation: it takes systemic strategies to treat a systemic syndrome
- Avaliação citométrica dos adipócitos localizados no tecido subcutâneo da parede anterior do abdome após infiltração percutânea de CO2
- Cytometric evaluation of abdominal subcutaneous adipocytes after percutaneous CO2 infiltration
- Perilipin expression in the subcutaneous adipose tissue in human cancer cachexia
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3286408.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
